Reference
- Killick J, Morisse G, Sieger D, Astier AL. Complement as a regulator
of adaptive immunity. Semin Immunopathol. 2018; 1:37-48.
- Kumar V. The complement system, toll-like receptors and inflammasomes
in host defense: three musketeers’ one target. Int Rev Immunol. 2019;
4:131-156.
- Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD. Interactions between
coagulation and complement–their role in inflammation. Semin
Immunopathol, 2020; 1:151-65.
- Haninger-Vacariu N, Aigner C, Kain R, Prohászka Z, Gaggl M, Böhmig GA,
et al. Successful Pregnancies During Ongoing Eculizumab Therapy in Two
Patients With Complement-Mediated Thrombotic Microangiopathy. Kidney
Med, 2020;, 2: 213-217.
- Lokki AI, Haapio M, Heikkinen-Eloranta J. Eculizumab Treatment for
Postpartum HELLP Syndrome and aHUS-Case Report. Front Immunol. 2020;
11:548.
- Luque A, Serrano I, Aran JM. Complement components as promoters of
immunological tolerance in dendritic cells. Semin Cell Dev Biol. 2019;
85:143-152.
- Meuleman T, Cohen D, Swings GM, Veraar K, Claas FH, Bloemenkamp KW.
Increased complement C4d deposition at the maternal-fetal interface in
unexplained recurrent miscarriage. J Reprod Immunol. 2016; 113:54-60.
- Galindo-Sevilla N, Reyes-Arroyo F, Mancilla-Ramírez J. The role of
complement in preterm birth and prematurity. J Perinat Med. 2019;
8:793-803.
- Chen L, Yue J, Han X, Li J, Hu Y. Ouabain rescues rat nephrogenesis
during intrauterine growth restriction by regulating the complement
and coagulation cascades and calcium signaling pathway. J Dev Orig
Health Dis. 2016; 1:91-101.
- Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D,
Roumenina L, et al. Mutations in complement regulatory proteins
predispose to preeclampsia: a genetic analysis of the PROMISSE cohort.
PLoS Med. 2011; 3:e1001013.
- Salmon JE, Heuser C, Triebwasser M, Liszewski Mk, Kavanagh D,
Roumenina L, et al. Direct evidence of complement activation in HELLP
syndrome: A link to atypical hemolytic uremic syndrome. Exp Hematol.
2016; 5:390-398.
- Girardi G. Complement activation, a threat to pregnancy. Semin
Immunopathol. 2018; 1:103-111.
- Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal
booking: systematic review of controlled studies. BMJ. 2005; 7491:565.
- Sjöberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a
delicate balance. Trends Immunol. 2009; 2:83-90.
- Webster RO, Hong SR, Johnston RB Jr, Henson PM. Biologial effects of
the human complement fragments C5a and C5ades Arg on neutrophil
function. Immunopharmacology. 1980; 3:201-219.
- Hänsch GM, Seitz M, Betz M. Effect of the late complement components
C5b-9 on human monocytes: release of prostanoids, oxygen radicals and
of a factor inducing cell proliferation. Int Arch Allergy Appl
Immunol. 1987; 3-4:317-320.
- Haeger M, Unander M, Andersson B, Tarkowski A, Arnestad JP, Bengtsson
A. Increased release of tumor necrosis factor-alpha and interleukin-6
in women with the syndrome of hemolysis, elevated liver enzymes, and
low platelet count. Acta Obstet Gynecol Scand. 1996; 8:695-701.
- Ma Y, Kong LR, Ge Q, Lu YY, Hong MN, Zhang Y, et al. Complement
5a-mediated trophoblasts dysfunction is involved in the development of
pre-eclampsia. J Cell Mol Med. 2018; 2:1034-1046.
- Morgan BP. The membrane attack complex as an inflammatory trigger.
Immunobiology. 2016; 6:747-751.
- Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP. The membrane
attack complex of complement causes severe demyelination associated
with acute axonal injury. J Immunol. 2002; 1:458-465.
- Guseh SH, Feinberg BB, Dawood HY, Yamamoto HS, Fichorova RN, Burwick
RM. Urinary excretion of C5b-9 is associated with the anti-angiogenic
state in severe preeclampsia. Am J Reprod Immunol. 2015; 5:437-444.
- De Falco M., Penta R., Laforgia V., Cobellis L., De Luca A. Apoptosis
and human placenta: expression of proteins belonging to different
apoptotic pathways during pregnancy. J Exp Clin Cancer Res
.2005;1:25-33.
- Gardiner C, Vatish M. Impact of haemostatic mechanisms on
pathophysiology of preeclampsia. Thromb Res. 2017; 151 Suppl
1:S48-S52.
- Trouw LA, Blom AM, Gasque P. Role of complement and complement
regulators in the removal of apoptotic cells. Mol Immunol. 2008;
5:1199-1207.
- Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile H, Bossi F, et
al. An alternative role of C1q in cell migration and tissue
remodeling: contribution to trophoblast invasion and placental
development. J Immunol. 2010; 7:4420-4429.
- Agostinis C, Tedesco F, Bulla R. Alternative functions of the
complement protein C1q at embryo implantation site. J Reprod Immunol.
2017; 119:74-80.
- Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement
activation induces dysregulation of angiogenic factors and causes
fetal rejection and growth restriction. J Exp Med. 2006; 9:2165-2175.
- Martin M, Leffler J, Blom AM. Annexin A2 and A5 serve as new ligands
for C1q on apoptotic cells. J Biol Chem. 2012; 40:33733-33744.
- Sellar GC, Cockburn D, Reid KB. Localization of the gene cluster
encoding the A, B, and C chains of human C1q to 1p34.1-1p36.3.
Immunogenetics. 1992; 3:214-216.
- Bobak DA, Gaither TA, Frank MM, Tenner AJ. Modulation of FcR function
by complement: subcomponent C1q enhances the phagocytosis of
IgG-opsonized targets by human monocytes and culture-derived
macrophages. J Immunol. 1987; 4:1150-1156.
- Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner
AJ. Antibody-mediated phagocytosis of the amyloid beta-peptide in
microglia is differentially modulated by C1q. J Immunol. 2001;
12:7496-7503.
- Korb LC, Ahearn JM. C1q binds directly and specifically to surface
blebs of apoptotic human keratinocytes: complement deficiency and
systemic lupus erythematosus revisited. J Immunol. 1997; 10:4525-4528.
- Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM. The globular heads
of C1q specifically recognize surface blebs of apoptotic vascular
endothelial cells. J Immunol. 2001; 5:3231-3239.
- Galvan MD, Greenlee-Wacker MC, Bohlson SS. C1q and phagocytosis: the
perfect complement to a good meal. J Leukoc Biol. 2012; 3:489-497.
- Ogden CA, deCathelineau A, Hoffmann PR. C1q and mannose binding lectin
engagement of cell surface calreticulin and CD91 initiates
macropinocytosis and uptake of apoptotic cells. J Exp Med.
2001;194:781-795.
- Stuart LM, Takahashi K, Shi L, Savill J, Ezekowitz RA. Mannosebinding
lectin-deficient mice display defective apoptotic cell clearance but
no autoimmune phenotype. J Immunol. 2005;174:3220-3226.
- Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, et al.
Impaired uptake of apoptotic cells into tingible body macrophages in
germinal centers of patients with systemic lupus erythematosus.
Arthritis Rheum. 2002; 1:191-201.
- Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, et al.
Clearance deficiency and systemic lupus erythematosus (SLE). J
Autoimmun. 2007; 23:114-21.
- 134.Hosszu KK, Santiago-Schwarz F, Peerschke EI, Ghebrehiwet B.
Evidence that a C1q/C1qR system regulates monocyte-derived dendritic
cell differentiation at the interface of innate and acquired immunity.
Innate Immun. 2010; 2:115-127.
- Benoit ME, Clarke EV, Morgado P, Fraser DA, Tenner AJ. Complement
protein C1q directs macrophage polarization and limits inflammasome
activity during the uptake of apoptotic cells. J Immunol. 2012;
11:5682-5693.
- Clarke EV, Weist BM, Walsh CM, Tenner AJ. Complement protein C1q bound
to apoptotic cells suppresses human macrophage and dendritic
cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol.
2015; 1:147-160.
- Yamada M, Oritani K, Kaisho T, Ishikawa J, Yoshida H, Takahashi I, et
al. Complement C1q regulates LPS-induced cytokine production in bone
marrow-derived dendritic cells. Eur J Immunol. 2004; 1:221-230.
- Fraser DA, Laust AK, Nelson EL, Tenner AJ. C1q differentially
modulates phagocytosis and cytokine responses during ingestion of
apoptotic cells by human monocytes, macrophages, and dendritic cells.
J Immunol. 2009; 10:6175-6185.
- Teh BK, Yeo JG, Chern LM, Lu J. C1q regulation of dendritic cell
development from monocytes with distinct cytokine production and T
cell stimulation. Mol Immunol. 2011; 9-10:1128-1138.
- Waggoner SN, Cruise MW, Kassel R, Hahn YS. gC1q receptor ligation
selectively down-regulates human IL-12 production through activation
of the phosphoinositide 3-kinase pathway [published correction
appears in J Immunol. 2007 Mar 1;1785;:3332]. J Immunol. 2005;
7:4706-4714.
- Lood C, Gullstrand B, Truedsson L, Olin AI, Alm GV, Rönnblom L, et al.
C1q inhibits immune complex-induced interferon-alpha production in
plasmacytoid dendritic cells: a novel link between C1q deficiency and
systemic lupus erythematosus pathogenesis. Arthritis Rheum. 2009;
10:3081-3090.
- Hosszu KK, Valentino A, Vinayagasundaram U, Vinayagasundaram R, Joyce
MG, Ji Y, et al. DC-SIGN, C1q, and gC1qR form a trimolecular receptor
complex on the surface of monocyte-derived immature dendritic cells.
Blood. 2012; 6:1228-1236.
- Manderson AP, Botto M, Walport MJ. The role of complement in the
development of systemic lupus erythematosus. Annu Rev Immunol. 2004;
22:431-456.
- Theofilopoulos AN, Gleicher N, Pereira AB, Dixon FJ. The biology of
immune complexes and their possible role in pregnancy. Prog Clin Biol
Res. 1981; 70:93-114.
- Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free
fetal DNA in maternal plasma are elevated prior to the onset of
preeclampsia. Hypertens Pregnancy. 2002; 1:77-83.
- Lokki AI, Heikkinen-Eloranta JK, Laivuori H. The Immunogenetic
Conundrum of Preeclampsia. Front Immunol. 2018; 9:2630. Published 2018
Nov 13.
- Szala A, Paradowska E, Nowakowska D, Swierzko AS,
Dzierzanowska-Fangrat K, Sokolowska A, et al. Mannan-binding lectin-2
MBL2; gene polymorphisms in prenatal and perinatal cytomegalovirus
infections. Mol Immunol. 2011; 15-16:2203-2206.
- Hayashi M. Aetiology of pre-eclampsia and thrombophilic genetic
mutations. Clin Sci Lond;. 2003; 3:269-271.
- Korb LC, Ahearn JM. C1q binds directly and specifically to surface
blebs of apoptotic human keratinocytes: complement deficiency and
systemic lupus erythematosus revisited. J Immunol. 1997; 0:4525-8.
- Scott D, Botto M. The paradoxical roles of C1q and C3 in autoimmunity.
Immunobiology. 2015.
- Singh J, Ahmed A, Girardi G. Role of complement component C1q in the
onset of preeclampsia in mice. Hypertension. 2011; 4:716-724.
- Ohmura K, Oku K, Kitaori T, Amengual O, Hisada R, Kanda M, et al.
Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss.
Clin Immunol. 2019; 203:37-44.
- Sutton EF, Gemmel M, Brands J, Gallaher MJ, Powers RW. Paternal
deficiency of complement component C1q leads to a preeclampsia-like
pregnancy in wild-type female mice and vascular adaptations
postpartum. Am J Physiol Regul Integr Comp Physiol. 2020;
6:R1047-R1057.
- Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, et
al. Mannose-binding lectin gene polymorphism is a modulating factor in
repeated respiratory infections. Chest. 2004; 1:95-99.
- Koucký M, Malíčková K, Kopřivová H, Cindrová-Davies T, Hrbáčková H,
Černý A ,et al. Low maternal serum concentrations of mannose-binding
lectin are associated with the risk of shorter duration of pregnancy
and lower birthweight. Scand J Immunol. 2018; 1:e12675.
- Kilpatrick DC, Bevan BH, Liston WA. Association between mannan binding
protein deficiency and recurrent miscarriage. Hum Reprod. 1995;
9:2501-2505.
- Wang FP, Wang MY, Guo XF, Shi RL, Xu SL, Ma SJ, et al. Zhongguo Shi
Yan Xue Ye Xue Za Zhi. 2013; 3:770-774.
- Han C, Jin J, Xu S, Liu H, Li N, Cao X. Mannan binding lectin
attenuates double-stranded RNA-mediated TLR3 activation and innate
immunity. FEBS Lett. 2014; 6:866-872.
- Wang M, Zhang Y, Chen Y, Zhang L, Lu X, Chen Z. Mannan-binding lectin
regulates dendritic cell maturation and cytokine production induced by
lipopolysaccharide. BMC Immunol. 2011; 12:1. Published 2011 Jan 1.
- Kilani RT, Mackova M, Davidge ST, Winkler-Lowen B, Demianczuk N,
Guilbert LJ. Endogenous tumor necrosis factor alpha mediates enhanced
apoptosis of cultured villous trophoblasts from intrauterine
growth-restricted placentae. Reproduction. 2007; 1:257-264.
- Pradhan V, Surve P, Ghosh K. Mannose binding lectin MBL; in
autoimmunity and its role in systemic lupus erythematosus SLE;. J
Assoc Physicians India. 2010; 58:688-690.
- Mahto H, Pati A, Sahu SK, Sharma HP, Padhi A, Panda AK. Association of
MBL-2 gene polymorphisms with systemic lupus erythematosus: an updated
meta-analysis and trial sequential analysis. Lupus. 2020;
10:1227-1237.
- Cieslinski JZ, Goeldner I, Skare TL, Nisihara R, Andrade FAD, Velavan
TP, et al. Mannose-binding lectin deficiency and miscarriages in
rheumatoid arthritis. Autoimmunity. 2017; 7:409-413.
- Christiansen OB, Kilpatrick DC, Souter V, Varming K, Thiel S,
Jensenius JC. Mannan-binding lectin deficiency is associated with
unexplained recurrent miscarriage. Scand J Immunol. 1999; 2:193-196.
- Kruse C, Rosgaard A, Steffensen R, Varming K, Jensenius JC,
Christiansen OB. Low serum level of mannan-binding lectin is a
determinant for pregnancy outcome in women with recurrent spontaneous
abortion. Am J Obstet Gynecol. 2002; 5:1313-1320.
- van de Geijn FE, Dolhain RJ, van Rijs W, Willemsen SP, Hazes JM, de
Groot CJ. Mannose-binding lectin genotypes are associated with shorter
gestational age. An evolutionary advantage of low MBL production
genotypes?. Mol Immunol. 2008; 5:1514-1518.
- Christiansen OB, Nielsen HS, Lund M, Steffensen R, Varming K.
Mannose-binding lectin-2 genotypes and recurrent late pregnancy
losses. Hum Reprod. 2009; 2:291-299.
- Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized,
double-blind, placebo-controlled trial of intravenous immunoglobulin
in the prevention of recurrent miscarriage: evidence for a therapeutic
effect in women with secondary recurrent miscarriage. Hum Reprod.
2002; 3:809-816.
- van de Geijn FE, Dolhain RJ, van Rijs W, Hazes JM, de Groot CJ.
Mannose-binding lectin genotypes and pre-eclampsia: a case-control
study. Hum Immunol. 2007; 11:888-893.
- Holmberg V, Schuster F, Dietz E, Sagarriga VJC, Anemana SD, Bienzle U,
et al. Mannose-binding lectin variant associated with severe malaria
in young African children. Microbes Infect. 2008; 4:342-348.
- Reichhardt MP, Lundin K, Lokki AI, Recher G, Vuoristo S, Katayama S,
et al. Tuuri Timo.(2019). Complement in Human Pre-implantation
Embryos: Attack and Defense. Front Immunol, 10(undefined), 2234.
- Goldberg M, Luknar-Gabor N, Keidar R, Katz Y. Synthesis of complement
proteins in the human chorion is differentially regulated by
cytokines. Mol Immunol. 2007; 7:1737-1742.
- Bulla R, Bossi F, Agostinis C, Radillo O, Colombo F, Seta FD, et al.
Complement production by trophoblast cells at the feto-maternal
interface. J Reprod Immunol. 2009; 2:119-125.
- Lokki AI, Aalto-Viljakainen T, Meri S, Laivuori H; FINNPEC. Genetic
analysis of membrane cofactor protein CD46; of the complement system
in women with and without preeclamptic pregnancies [published
correction appears in PLoS One. 2015; 4:e0125449.
- Buurma A, Cohen D, Veraar K, Schonkeren D, Claas FH, Bruijn JA, et al.
Preeclampsia is characterized by placental complement dysregulation.
Hypertension. 2012; 5:1332-1337.
- Khera R, Das N. Complement receptor 1: disease associations and
therapeutic implications. Mol Immunol. 2009;46:761–772.
- Springer T, Galfre G, Secher DS, Milstein C. Mac-1: a macrophage
differentiation antigen identified by monoclonal antibody. Eur J
- Immunol. 1979;9:301–306.
- Vik DP, Fearon DT. Cellular distribution of complement receptor type 4
(CR4): expression on human platelets. J Immunol. 1987;138:254–258.
- Morelli AE, Larregina AT, Shufesky WJ, Zahorchak AF, Logar AJ, Glenn
DP, et al. Internalization of circulating apoptotic cells by splenic
marginal zone dendritic cells: dependence on complement receptors and
effect on cytokine production. Blood. 2003; 2:611-620.
- Mukai R, Okunuki Y, Husain D, Kim CB, Lambris JD, Connor KM. The
Complement System Is Critical in Maintaining Retinal Integrity during
Aging. Front Aging Neurosci. 2018; 10:15. Published 2018 Feb 15.
Published 2018 Feb 15.
- Silverman SM, Ma W, Wang X, Zhao L, Wong WT. C3- and CR3-dependent
microglial clearance protects photoreceptors in retinitis pigmentosa.
J Exp Med. 2019; 8:1925-1943.
- Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired
clearance of dying cells in systemic lupus erythematosus. Autoimmun
Rev. 2005; 4:189-194.
- Sacks SH. Complement fragments C3a and C5a: the salt and pepper of the
immune response. Eur J Immunol. 2010; 3:668-670.
- Wilson JG, Tedder TF, Fearon DT. Characterization of human T
lymphocytes that express the C3b receptor. J Immunol. 1983; 2:684-689.
- Mouhoub A, Delibrias CC, Fischer E, Boyer V, Kazatchkine MD. Ligation
of CR1 C3b receptor, CD35; on CD4+ T lymphocytes enhances viral
replication in HIV-infected cells. Clin Exp Immunol. 1996; 2:297-303.
- Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key
system for immune surveillance and homeostasis. Nat Immunol. 2010;
9:785-797. doi:10.1038/ni.1923
- Kolev M, Le Friec G, Kemper C. Complement–tapping into new sites
and effector systems. Nat Rev Immunol. 2014; 12:811-820.
- Kremlitzka M, Polgár A, Fülöp L, Kiss E, Poór G, Erdei A. Complement
receptor type 1 CR1, CD35; is a potent inhibitor of B-cell functions
in rheumatoid arthritis patients. Int Immunol. 2013; 1:25-33.
- Mácsik-Valent B, Nagy K, Fazekas L, Erdei A. Complement Receptor Type
1 CR1, CD35;, the Inhibitor of BCR-Mediated Human B Cell Activation,
Differentially Regulates TLR7, and TLR9 Induced Responses. Front
Immunol. 2019; 10:1493.
- Beurskens FJ, van Schaarenburg RA, Trouw LA. C1q, antibodies and
anti-C1q autoantibodies. Mol Immunol. 2015; 1:6-13.
- Wu J, Ma J, Zhang WH, Di W. Management and outcomes of pregnancy with
or without lupus nephritis: a systematic review and meta-analysis.
Ther Clin Risk Manag. 2018; 14:885-901. Published 2018 May 11.
- Khera R, Das N. Complement Receptor 1: disease associations and
therapeutic implications. Mol Immunol. 2009; 5:761-772.
- Feinberg BB, Jack RM, Mok SC, Anderson DJ. Low erythrocyte complement
receptor type 1 CR1, CD35; expression in preeclamptic gestations. Am J
Reprod Immunol. 2005; 6:352-357.
- McElroy JJ, Gutman CE, Shaffer CM, Busch TD, Puttonen H, Teramo K, et
al. Maternal coding variants in complement receptor 1 and spontaneous
idiopathic preterm birth. Hum Genet. 2013; 8:935-942.
- Fagerholm SC, Guenther C, Llort Asens M, Savinko T, Uotila LM.
Beta2-Integrins and Interacting Proteins in Leukocyte Trafficking,
Immune Suppression, and Immunodeficiency Disease. Front Immunol. 2019;
10:254. Published 2019 Feb 19.
- Norris GT, Smirnov I, Filiano AJ, Shadowen HM, Cody KR, Thompson JA,
et al. Neuronal integrity and complement control synaptic material
clearance by microglia after CNS injury. J Exp Med. 2018; 7:1789-1801.
- Amarilyo G, Verbovetski I, Atallah M, Grau M, Wiser G, Gil O, et al.
iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory
response and transcriptional NF-kappaB-dependent blockade. Eur J
Immunol. 2010; 3:699-709.
- Wang L, Gordon RA, Huynh L, Su X, Min KP, Han J, et al. Indirect
inhibition of Toll-like receptor and type I interferon responses by
ITAM-coupled receptors and integrins. Immunity. 2010; 4:518-530.
- Han C, Jin J, Xu S, Liu H, Li N, Cao X. Integrin CD11b negatively
regulates TLR-triggered inflammatory responses by activating Syk and
promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol. 2010;
8:734-742.
- Sohn JH, Bora PS, Suk HJ, Molina H, Kaplan HJ, Bora NS. Tolerance is
dependent on complement C3 fragment iC3b binding to antigen-presenting
cells. Nat Med. 2003; 2:206-212.
- Luo X, Liu L, Tang N, Lu KQ, McCormick TS, Kang K, et al. Inhibition
of monocyte-derived dendritic cell differentiation and interleukin-12
production by complement iC3b via a mitogen-activated protein kinase
signalling pathway. Exp Dermatol. 2005; 4:303-310.
- Vogt L, Schmitz N, Kurrer MO, Bauer M, Hinton HI, Behnke S, et al.
VSIG4, a B7 family-related protein, is a negative regulator of T cell
activation. J Clin Invest. 2006; 10:2817-2826.
- Kim S, Iizuka K, Kang HP, Dokun A, French AR, Greco S, et al. In vivo
developmental stages in murine natural killer cell maturation. Nat
Immunol. 2002; 6:523-528.
- Min X, Liu C, Wei Y, Wang N, Yuan G, Liu Dan, et al. Expression and
regulation of complement receptors by human natural killer cells.
Immunobiology. 2014; 9:671-679.
- Liu CF, Min XY, Wang NY, Wang JX, Ma N, Dong X, et al. Complement
Receptor 3 Has Negative Impact on Tumor Surveillance through
Suppression of Natural Killer Cell Function. Front Immunol. 2017;
8:1602. Published 2017 Nov 20.
- Nowatzky J, Manches O, Khan SA, Godefroy E, Bhardwaj N. Modulation of
human Th17 cell responses through complement receptor 3 CD11 b/CD18;
ligation on monocyte-derived dendritic cells. J Autoimmun. 2018;
92:57-66.
- Ehirchiou D, Xiong Y, Xu G, Chen W, Shi Y, Zhang L. CD11b facilitates
the development of peripheral tolerance by suppressing Th17
differentiation. J Exp Med. 2007; 7:1519-1524.
- Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS, et
al. A nonsynonymous functional variant in integrin-alphaM; encoded by
ITGAM; is associated with systemic lupus erythematosus. Nat Genet.
2008; 2:152-154.
- MacPherson M, Lek HS, Prescott A, Fagerholm SC. A systemic lupus
erythematosus-associated R77H substitution in the CD11b chain of the
Mac-1 integrin compromises leukocyte adhesion and phagocytosis. J Biol
Chem. 2011; 19:17303-17310.
- Chow WN, Lee YL, Wong PC, Chung MK, Lee KF, Yeung WS. Complement 3
deficiency impairs early pregnancy in mice. Mol Reprod Dev. 2009;
7:647-655.
- Nakamura K, Kusama K, Bai R, Ishikawa S, Fukushima S, Suda Y, et al.
Increase in complement iC3b is associated with anti-inflammatory
cytokine expression during late pregnancy in mice. PLoS One. 2017;
5:e0178442. Published 2017 May 25.
- Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and
the interleukin-10 receptor. Annu Rev Immunol. 2001; 19:683-765.
- Lokki AI, Heikkinen-Eloranta J, Jarva H, Saisto T, Lokki ML, Laivuori
H, et al. Complement activation and regulation in preeclamptic
placenta. Front Immunol. 2014; 5:312.
- Martin Myriam., Blom Anna M.(2016). Complement in removal of the dead
- balancing inflammation. Immunol Rev, 2016; 1, 218-232.
- 42.Derzsy Z, Prohászka Z, Rigó J Jr, Füst G, Molvarec A. Activation of
the complement system in normal pregnancy and preeclampsia. Mol
Immunol. 2010; 7-8:1500-1506.
- Burwick RM, Velásquez JA, Valencia CM, Gutiérrez-Marín J, Edna-Estrada
F, Silva JL, et al.Terminal Complement Activation in Preeclampsia.
Obstet Gynecol, 2018; 6: 1477-1485.